6 results on '"Castelletti, Silvia"'
Search Results
2. [Cardiology as seen through social media]
- Author
-
Castelletti, Silvia, Di Fusco, Stefania Angela, Borrelli, Nunzia, Gragnano, Felice, Perone, Francesco, Colivicchi, Furio, Castelletti, Silvia, Di Fusco, Stefania Angela, Borrelli, Nunzia, Gragnano, Felice, Perone, Francesco, and Colivicchi, Furio
- Subjects
Cardiology ,Humans ,COVID-19 ,Social Media ,Pandemics ,Cardiovascular System - Abstract
The use of social media (SoMe) has spread worldwide among doctors, scientific societies, and researchers. SoMe offer a powerful platform to accelerate or create new contacts, spread scientific news, and increase visibility. A social media promotion strategy for cardiovascular medicine papers seems to be associated with increased online visibility and a higher number of citations. This effect is independent of the type of article and the total number of followers of the authors. Indeed, SoMe are democratic and even non-senior researchers may be popular on Twitter: your title is not as important as what you do on Twitter. Nevertheless, some physicians may be over-celebrated due to their presence on SoMe. This is why a new author index, the K-index, has been proposed. The K-index correlates the citations of a scientist with the number of Twitter followers. Even scientific journals and societies have recognized the importance of SoMe and in the last years they have appeared on SoMe with official accounts. Therefore, besides the classic impact factor, publishers now pay more and more attention to other parameters, such as the Altmetric score, which takes into account the number of citations, but also the number of downloads, mentions on SoMe, newspapers and tv news, web sites, and blogs. The COVID-19 pandemic has boosted the importance of SoMe for scientific content distribution, particularly for congresses. For all these reasons, it is important to understand the pros and cons of SoMe. It is also possible that SoMe will become a new education medium for continuing medical education.
- Published
- 2022
3. 3 Beyond 15mm: towards a new personalised, AI measured definition of hypertrophic cardiomyopathy using an age, sex, and body surface area -adjusted approach
- Author
-
Shiwani Hunain, Davies Rhodri, Augusto Joao, Hughes Rebecca, Lopes Luis, Artico Jessica, Rosmini Stefania, Castelletti Silvia, Joy George, Pierce Iain, Xue Hui, Kellman Peter, Hughes Alun, Treibel Thomas, Manisty Charlotte, Mohiddin Saidi, Captur Gaby, and Moon James C
- Published
- 2023
- Full Text
- View/download PDF
4. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
- Author
-
Collet, Jean-Philippe, Thiele, Holger, Barbato, Emanuele, Barthélémy, Olivier, Bauersachs, Johann, Bhatt, Deepak, Dendale, Paul, Dorobantu, Maria, Edvardsen, Thor, Folliguet, Thierry, Gale, Chris, Gilard, Martine, Jobs, Alexander, Jüni, Peter, Lambrinou, Ekaterini, Lewis, Basil, Mehilli, Julinda, Meliga, Emanuele, Merkely, Béla, Mueller, Christian, Roffi, Marco, Rutten, Frans, Sibbing, Dirk, Siontis, George, Kastrati, Adnan, Mamas, Mamas, Aboyans, Victor, Angiolillo, Dominick, Bueno, Hector, Bugiardini, Raffaele, Byrne, Robert, Castelletti, Silvia, Chieffo, Alaide, Cornelissen, Veronique, Crea, Filippo, Delgado, Victoria, Drexel, Heinz, Gierlotka, Marek, Halvorsen, Sigrun, Haugaa, Kristina Hermann, Jankowska, Ewa, Katus, Hugo, Kinnaird, Tim, Kluin, Jolanda, Kunadian, Vijay, Landmesser, Ulf, Leclercq, Christophe, Lettino, Maddalena, Meinila, Leena, Mylotte, Darren, Ndrepepa, Gjin, Omerovic, Elmir, Pedretti, Roberto, Petersen, Steffen, Petronio, Anna Sonia, Pontone, Gianluca, Popescu, Bogdan, Potpara, Tatjana, Ray, Kausik, Luciano, Flavio, Richter, Dimitrios, Shlyakhto, Evgeny, Simpson, Iain, Sousa-Uva, Miguel, Storey, Robert, Touyz, Rhian, Valgimigli, Marco, VRANCKX, PASCAL, Yeh, Robert, Collet, Jean-Philippe, Thiele, Holger, Barbato, Emanuele, Barthélémy, Olivier, Bauersachs, Johann, Bhatt, Deepak L, Dendale, Paul, Dorobantu, Maria, Edvardsen, Thor, Folliguet, Thierry, Gale, Chris P, Gilard, Martine, Jobs, Alexander, Jüni, Peter, Lambrinou, Ekaterini, Lewis, Basil S, Mehilli, Julinda, Meliga, Emanuele, Merkely, Béla, Mueller, Christian, Roffi, Marco, Rutten, Frans H, Sibbing, Dirk, Siontis, George C M, Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Institute of cardiometabolism and nutrition (ICAN), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut de cardiologie [CHU Pitié-Salpêtrière], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Pitié-Salpêtrière [AP-HP], Collet J.-P., Thiele H., Barbato E., Bauersachs J., Dendale P., Edvardsen T., Gale C.P., Jobs A., Lambrinou E., Mehilli J., Merkely B., Roffi M., Sibbing D., Kastrati A., Mamas M.A., Aboyans V., Angiolillo D.J., Bueno H., Bugiardini R., Byrne R.A., Castelletti S., Chieffo A., Cornelissen V., Crea F., Delgado V., Drexel H., Gierlotka M., Halvorsen S., Haugaa K.H., Jankowska E.A., Katus H.A., Kinnaird T., Kluin J., Kunadian V., Landmesser U., Leclercq C., Lettino M., Meinila L., Mylotte D., Ndrepepa G., Omerovic E., Pedretti R.F.E., Petersen S.E., Petronio A.S., Pontone G., Popescu B.A., Potpara T., Ray K.K., Luciano F., Richter D.J., Shlyakhto E., Simpson I.A., Sousa-Uva M., Storey R.F., Touyz R.M., Valgimigli M., Vranckx P., Yeh R.W., Barthelemy O., Bhatt D.L., Dorobantu M., Folliguet T., Gilard M., Juni P., Lewis B.S., Meliga E., Mueller C., Rutten F.H., and Siontis G.C.M.
- Subjects
unstable angina ,Myocardial ischaemia ,[SDV]Life Sciences [q-bio] ,Vascular damage Radboud Institute for Health Sciences [Radboudumc 16] ,dual antithrombotic therapy ,Guideline ,heparin ,030204 cardiovascular system & hematology ,Platelet inhibition ,antiplatelet ,0302 clinical medicine ,ST segment ,Medicine ,dabigatran ,Myocardial infarction ,guidelines ,glycoprotein iib/iiia inhibitors ,anticoagulation ,Non-ST Elevated Myocardial Infarction ,rivaroxaban ,ComputingMilieux_MISCELLANEOUS ,reproductive and urinary physiology ,diabetes ,bleedings ,bivalirudin ,atherothrombosi ,Disease Management ,angioplasty ,Guidelines • acute cardiac care • acute coronary syndrome • angioplasty • anticoagulation • antiplatelet • apixaban • aspirin • atherothrombosis • betablockers • bleedings • bivalirudin • bypass surgery • cangrelor • chest pain unit • clopidogrel • dabigatran • diabetes • dual antithrombotic therapy • early invasive strategy • edoxaban • enoxaparin • European Society of Cardiology • fondaparinux • glycoprotein IIb/ IIIa inhibitors • heparin • high-sensitivity troponin • minoca • myocardial ischaemia • myocardial infarction • nitrates • non-ST-elevation myocardial infarction • platelet inhibition • prasugrel • recommendations • revascularization • rhythm monitoring • rivaroxaban • stent • ticagrelor • triple therapy • unstable angina ,enoxaparin ,General Medicine ,Clopidogrel ,3. Good health ,early invasive strategy ,myocardial infarction ,triple therapy ,030220 oncology & carcinogenesis ,High sensitivity troponin ,embryonic structures ,Cardiology ,Platelet aggregation inhibitor ,revascularization ,biological phenomena, cell phenomena, and immunity ,Cardiology and Cardiovascular Medicine ,Ticagrelor ,medicine.drug ,Human ,recommendation ,Acute coronary syndrome ,medicine.medical_specialty ,aspirin ,glycoprotein IIb/IIIa inhibitor ,non-ST-elevation myocardial infarction ,apixaban ,rhythm monitoring ,European Society of Cardiology ,ticagrelor ,03 medical and health sciences ,nitrate ,atherothrombosis ,betablockers ,Internal medicine ,acute cardiac care ,minoca ,chest pain unit ,Diseases of the circulatory (Cardiovascular) system ,Humans ,In patient ,Acute Coronary Syndrome ,clopidogrel ,Unstable angina ,urogenital system ,nitrates ,business.industry ,fondaparinux ,betablocker ,Arrhythmias, Cardiac ,030229 sport sciences ,bleeding ,medicine.disease ,myocardial ischaemia ,platelet inhibition ,prasugrel ,diabete ,Glycoprotein IIb/IIIa inhibitors ,RC666-701 ,bypass surgery ,Settore MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLARE ,recommendations ,edoxaban ,high-sensitivity troponin ,stent ,business ,Platelet Aggregation Inhibitors ,cangrelor - Abstract
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
- Published
- 2021
- Full Text
- View/download PDF
5. Clinical recommendations of cardiac magnetic resonance, Part I: ischemic and valvular heart disease: a position paper of the working group 'Applicazioni della Risonanza Magnetica' of the Italian Society of Cardiology
- Author
-
Aquaro, Giovanni Donato, Di Bella, Gianluca, Castelletti, Silvia, Maestrini, Viviana, Festa, Pierluigi, Ait Ali, Lamia, Masci, Pier Giorgio, Monti, Lorenzo, di Giovine, Gabriella, DE LAZZARI, Manuel, Cipriani, Alberto, Guaricci, Andrea I., Dellegrottaglie, Santo, Pepe, Alessia, PERAZZOLO MARRA, Martina, and Pontone, Gianluca
- Subjects
Consensus ,Cost-Benefit Analysis ,Cardiology ,Heart Valve Diseases ,Myocardial Ischemia ,Contrast Media ,Magnetic Resonance Imaging, Cine ,Reproducibility of Results ,Health Care Costs ,Prognosis ,ischemic heart disease ,Severity of Illness Index ,cardiac magnetic resonance ,cardiology and cardiovascular medicine ,Appropriateness criteria ,Cardiac magnetic resonance ,Ischemic heart disease ,Valvular heart disease ,Cardiology and Cardiovascular Medicine ,valvular heart disease ,Predictive Value of Tests ,appropriateness criteria ,Humans - Abstract
Cardiac magnetic resonance (CMR) has emerged as a reliable and accurate diagnostic tool for the evaluation of patients with cardiac disease in several clinical settings and with proven additional diagnostic and prognostic value compared with other imaging modalities. This document has been developed by the working group on the 'application of CMR' of the Italian Society of Cardiology to provide a perspective on the current state of technical advances and clinical applications of CMR and to inform cardiologists on how to implement their clinical and diagnostic pathways with the inclusion of this technique in clinical practice. The writing committee consisted of members of the working group of the Italian Society of Cardiology and two external peer reviewers with acknowledged experience in the field of CMR.
- Published
- 2017
6. Management of nonischemic-dilated cardiomyopathies in clinical practice: a position paper of the working group on myocardial and pericardial diseases of Italian Society of Cardiology
- Author
-
Ugolino Livi, Cristina Basso, Gianfranco Sinagra, G. Lardieri, Barbara Bauce, Antonio Cannatà, Massimo Imazio, Marco Merlo, Giuseppe Limongelli, Marco Masè, Martina Perazzolo Marra, Denise Zaffalon, Camillo Autore, Elena Biagini, Silvia Castelletti, Giovanni Maria Severini, Matteo Dal Ferro, Marco Canepa, Merlo, Marco, Masè, Marco, Cannatà, Antonio, Zaffalon, Denise, Lardieri, Gerardina, Limongelli, Giuseppe, Imazio, Massimo, Canepa, Marco, Castelletti, Silvia, Bauce, Barbara, Biagini, Elena, Livi, Ugolino, Severini, Giovanni M, Dal Ferro, Matteo, Marra, Martina Perazzolo, Basso, Cristina, Autore, Camillo, and Sinagra, Gianfranco
- Subjects
Cardiomyopathy, Dilated ,medicine.medical_specialty ,Consensus ,Time Factors ,Referral ,diagnosis ,management ,network ,nonischemic cardiomyopathy ,Clinical Decision-Making ,Cardiology ,Cardiomyopathy ,MEDLINE ,030204 cardiovascular system & hematology ,03 medical and health sciences ,0302 clinical medicine ,Predictive Value of Tests ,Risk Factors ,medicine ,Humans ,030212 general & internal medicine ,Cooperative Behavior ,Intensive care medicine ,Referral and Consultation ,Patient Care Team ,Delivery of Health Care, Integrated ,business.industry ,Dilated cardiomyopathy ,General Medicine ,Prognosis ,medicine.disease ,Clinical Practice ,Cardiac Imaging Techniques ,Heart failure ,Heart Function Tests ,Pericardial diseases ,Position paper ,Interdisciplinary Communication ,Cardiology and Cardiovascular Medicine ,business - Abstract
Nonischemic-dilated cardiomyopathy (NIDCM) is an entity that gathers extremely heterogeneous diseases. This awareness, although leading to continuous improvement in survival, has increased the complexity of NIDCM patients' management. Even though the endorsed 'red-flags' approach helps clinicians in pursuing an accurate etiological definition in clinical practice, it is not clear when and how peripheral centers should interact with referral centers with specific expertise in challenging scenarios (e.g. postmyocarditis and genetically determined dilated cardiomyopathy) and with easier access to second-line diagnostic tools and therapies. This position paper will summarize each step in NIDCM management, highlighting the multiple interactions between peripheral and referral centers, from first-line diagnostic workup and therapy to advanced heart failure management and long-term follow-up.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.